Anera Life Inc. is proud to announce the appointment of Dr. Dean Raffelock to its Scientific Advisory Board, strengthening the company’s existing scientific leadership and expanding its growing ecosystem of clinical expertise in longevity and cellular health.
Anera’s Scientific Advisory Board was created to support the ongoing efforts of our Chief Science Officer – Dr Andrew Willoughby and his continuing initiatives to create a novel line of Hyper-Dense Longevity Supplements (“HDLS’s”) and Protocols (“HDLP’s”).
Dr. Raffelock has earned 5 board certifications as an integrative doctor and is one of the most respected formulators in the industry. With over 40 years of leadership in clinical nutrition, nutraceutical R&D, and functional food product development, he has created and helped launch over 50 science-backed wellness products.
Dean’s extensive background spans nutrigenomics, mitochondrial science, endocrine optimization, and evidence-based product formulation.
Dean’s focus aligns perfectly with Anera’s mission: solve root causes of biological dysfunction, microbiome damage, mitochondrial decline, and metabolic breakdown, not just symptoms.
Dr. Raffelock shared:
“One of the biggest problems in our industry is the overuse of antibiotic, antifungal and antiviral drugs, which damage both the oral and gut microbiomes and impair mitochondrial function and biogenesis. Anera is taking a completely unique approach to solving this problem. I believe it could be a major paradigm-shift for the entire field of healthcare. I am honoured to be asked to join this group of cutting edge doctors dedicated to developing new products and health strategies for this new millennium”.
Dr Raffelock has served in numerous advisory and leadership roles across the integrative health, functional nutrition, and nutraceutical sectors, helping guide product development and clinical strategy for companies dedicated to improving human health.
In his new advisory capacity, Dr. Raffelock will support Anera’s Scientific Advisory Board with a focus on:
- Clinical review and validation of ingredient research
- Guidance on evidence-based formulation strategy
- Biochemical and nutrigenomic considerations for product architecture
- Scientific communication and education
- Strategic input as to future longevity-based innovations
This appointment further reinforces Anera’s commitment to developing pharmaceutical-grade longevity supplements built on clinical evidence, regulatory integrity, and a science-first philosophy.
“We are honoured to welcome Dr. Raffelock to Anera,” said Truc Tran, Founder & CEO.
“His experience in functional medicine and biochemical analysis will strengthen our ability to develop advanced, clinically relevant hyper-dense nutritional supplements that reflect our mission: to help heal humanity and extend human healthspan.”
This appointment marks another step in Anera’s evolution from a premium supplement brand to a scientifically governed, longevity organization building for global impact.
About Anera Life Inc.
Anera Life Inc. is a Canadian longevity company dedicated to scientific, pharmaceutical-grade solutions for cellular health and healthy aging. Anera’s formulations are based on clinically validated ingredients, Health Canada regulatory oversight, and a commitment to evidence-based product development.
For more information, please contact either:
Mr. Truc Tran
Founder & CEO
Anera Life, Inc
E> truc@aneralife.com
M> 1.604.719.6869
or
Dr. Andrew Willoughby
President & Chief Science Officer
Anera Life, Inc
E> andrew@aneralife.com
M> 1.604.780.8159
